Where does Progyny's cash flow data come from?

Every line is extracted from Progyny's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Progyny PGNY Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Net income	$58.52M+7.7%	$54.34M-12.4%	$62.04M+104%	$30.36M-53.8%
Depreciation and amortization	$4.95M+55.8%	$3.18M+39.2%	$2.28M+42.5%	$1.6M+23.1%
Stock-based compensation	$131.87M+2.9%	$128.13M+4.5%	$122.61M+21.7%	$100.75M+199%
Deferred income taxes	-$8.12M+22.4%	-$10.46M—	——	——
Gain (loss) on sale of assets	——	-$1.41M—	$0—	$0—
Provision for credit losses	$20.53M+25.2%	$16.4M-17.7%	$19.93M+44.5%	$13.79M+41.0%
Change in accounts receivable	——	——	——	——
Change in accounts payable	——	-$30.27M—	——	$47.69M—
Change in accrued liabilities	——	——	——	——
Change in other assets	——	——	——	——
Net cash from operating activities	$210.19M+17.4%	$179.11M-5.1%	$188.81M+135%	$80.4M+209%
Capital expenditures	$18.41M+241%	$5.41M+48.3%	$3.64M+12.4%	$3.24M+52.2%
Acquisitions, net of cash acquired	——	——	——	$0—
Purchases of investments	$354.96M+108%	$170.34M-60.4%	$429.69M+163%	$163.33M+46.5%
Proceeds from maturities/sales of investments	$223.7M-40.6%	$376.84M+61.9%	$232.81M+89.7%	$122.71M+0.3%
Net cash from investing activities	-$167.27M-185%	$195.79M+198%	-$200.53M-357%	-$43.87M—
Repurchases of common stock	$81.66M-72.8%	$300.28M—	$0—	$0—
Proceeds from issuance of common stock	——	$1.1M-77.3%	$4.85M+57.8%	$3.07M+5.1%
Taxes paid for net share settlement	$15.85M+32.1%	$12M-30.2%	$17.2M+42.3%	$12.09M-32.7%
Net cash from financing activities	-$99.36M+67.9%	-$309.88M-2,699%	-$11.07M-40.8%	-$7.86M+42.6%
Effect of exchange rate changes on cash	$65K+6,400%	$1K0.0%	$1K—	——
Net increase (decrease) in cash	——	$65.02M+385%	-$22.78M—	——
Income taxes paid	$55.49M+37.2%	$40.45M+554%	$6.18M+4,134%	$146K—
Accrued expenses and other liabilities	——	——	——	——
Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net	$9.31M—	——	——	——
Increase (Decrease) in Prepaid Expense and Other Assets	——	——	——	——
Accounts Receivable, Credit Loss Expense (Reversal)	$20.53M+25.2%	$16.4M-17.7%	$19.93M+44.5%	$13.79M+41.0%
Sale of investments	$223.7M-40.6%	$376.84M+61.9%	$232.81M+89.7%	$122.71M+0.3%
Issuance of stock under employee stock plans	$1.14M-12.0%	$1.3M+1.7%	$1.28M+10.9%	$1.15M-14.5%
Accrued payables for capital expenditures	——	$263K—	——	——
Non-cash interest expense	——	$0+100%	-$34K—	——
Income Taxes Paid, Net	$55.49M+37.2%	$40.45M+554%	$6.18M+4,134%	$146K—
Free cash flow	$191.78M+10.4%	$173.7M-6.2%	$185.17M+140%	$77.15M+223%
Free cash flow	$191.78M+10.4%	$173.7M-6.2%	$185.17M+140%	$77.15M+223%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does Progyny's cash flow data come from?: Every line is extracted from Progyny's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.